Bandaríkin - enska - NLM (National Library of Medicine)

b. braun medical inc. - isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), alanine (unii: of5 - isoleucine 0.69 g in 100 ml - parenteral nutrition with 10% freamine® iii (amino acid injection) is indicated to prevent nitrogen loss or treat negative nitrogen balance in adults and pediatric patients where (1) the alimentary tract, by the oral, gastrostomy, or jejunostomy route, cannot or should not be used, or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of protein is impaired; or (3) protein requirements are substantially increased as with extensive burns. dosage, route of administration, and concomitant infusion of nonprotein calories are dependent on various factors, such as nutritional and metabolic status of the patient, anticipated duration of parenteral nutritional support, and vein tolerance. see warnings, precautions, pediatric use , and dosage and administration. central venous infusion should be considered when amino acid solutions are to be admixed with hypertonic dextrose to promote protein synthesis in hypercatabolic or severely depleted patients, or those requiring long-term

Bandaríkin - enska - NLM (National Library of Medicine)

gm holdings co., ltd - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz), panthenol (unii: wv9cm0o67z) (panthenol - unii:wv9cm0o67z), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - salicylic acid 0.001 in 150 ml

Bandaríkin - enska - NLM (National Library of Medicine)

b. braun medical inc. - histidine (unii: 4qd397987e) (histidine - unii:4qd397987e), isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii - histidine 0.25 g in 100 ml - 5.4% nephramine® (essential amino acid injection) is indicated for adult and pediatric use, in conjunction with other measures, to provide nutritional support for uremic patients, particularly when oral nutrition is infeasible or impractical. see warnings, precautions, pediatric use , special precautions in pediatric patients , and dosage and administration . nephramine® is contraindicated in patients with severe, uncorrected electrolyte and acid-base imbalance, hyperammonemia, decreased (subcritical) circulating blood volume, inborn errors of amino acid metabolism, or hypersensitivity to one or more amino acids present in the solution.

Bandaríkin - enska - NLM (National Library of Medicine)

b. braun medical inc. - isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), alanine (unii: of5 - isoleucine 0.9 g in 100 ml - hepatamine® is indicated for the treatment of hepatic encephalopathy in patients with cirrhosis or hepatitis. hepatamine® provides nutritional support for patients with these diseases of the liver who require parenteral nutrition and are intolerant of general purpose amino acid injections, which are contraindicated in patients with hepatic coma. hepatamine® is contraindicated in patients with anuria, inborn errors of amino acid metabolism, especially those involving branched chain amino acid metabolism such as maple syrup urine disease and isovaleric acidemia, or hypersensitivity to one or more amino acids present in the solution.

Bandaríkin - enska - NLM (National Library of Medicine)

baxter healthcare corporation - leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), lysine hydrochloride (unii: jnj23q2com) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), histidine (unii: 4qd397987e) (histidine - unii:4qd397987e), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (un - leucine 730 mg in 100 ml - travasol is indicated as a source of amino acids for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. travasol may be used to treat negative nitrogen balance in patients. the use of travasol is contraindicated in: risk summary limited published data with injectable amino acids solutions, including travasol in pregnant women are not sufficient to inform a drug associated risk for adverse developmental outcomes. however, malnutrition in pregnant women is associated with adverse maternal and fetal outcomes [see clinical considerations]. animal reproduction studies have not been conducted with injectable amino acids solutions, including travasol. the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. however, the background risk in the u.s. general population of major birth defects is 2 to 4% and of miscar

Bandaríkin - enska - NLM (National Library of Medicine)

ceela naturals,llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 20 mg in 1 ml - acne, psoriasis and seborrheic dermatitis treatment • treating acne • dries up acne pimples  • helps prevent new acne pimples • eliminates seborrhea and dandruff • helps itching, redness, scaling

Bandaríkin - enska - NLM (National Library of Medicine)

bliss world llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 3 mg in 15 ml - purpose acne treatment uses - for the treatment of acne - helps clear up blackheads - helps prevent new acne blemishes - penetrates pores to eliminate most acne pimples

Bandaríkin - enska - NLM (National Library of Medicine)

alberto-culver usa inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 0.02 ml in 1 ml - for treatment of acne use for treatment of acne

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

vantive ltd - l-tyrosine; l-tryptophan; l-serine; l-proline; glycine; l-alanine; l-valine; l-isoleucine; l-leucine; l-lysine monohydrochloride; l-histidine; l-arginine; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium lactate; sodium chloride; l-threonine; l-phenylalanine; l-methionine - solution for peritoneal dialysis - 300mg/1litre ; 270mg/1litre ; 510mg/1litre ; 595mg/1litre ; 510mg/1litre ; 951mg/1litre ; 1.393gram/1litre ; 850mg/1litre ; 1.02gram/1litre ; 955mg/1litre ; 714mg/1litre ; 1.071gram/1litre ; 184mg/1litre ; 51mg/1litre ; 4.48gram/1litre ; 5.38gram/1litre ; 646mg/1litre ; 570mg/1litre ; 850mg/1litre

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - l-tyrosine; l-tryptophan; l-serine; l-proline; glycine; l-alanine; l-valine; l-isoleucine; l-leucine; l-lysine monohydrochloride; l-histidine; l-arginine; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium lactate; sodium chloride; l-threonine; l-phenylalanine; l-methionine - solution for peritoneal dialysis - 300mg/1litre ; 270mg/1litre ; 510mg/1litre ; 595mg/1litre ; 510mg/1litre ; 951mg/1litre ; 1.393gram/1litre ; 850mg/1litre ; 1.02gram/1litre ; 955mg/1litre ; 714mg/1litre ; 1.071gram/1litre ; 184mg/1litre ; 51mg/1litre ; 4.48gram/1litre ; 5.38gram/1litre ; 646mg/1litre ; 570mg/1litre ; 850mg/1litre